$79.99
Price
$1.8B
Market Cap
20.5
P/E Ratio
7.5
Forward P/E
$3.91
EPS (TTM)
—
Dividend Yield
$326M
Cash
$617M
Total Debt
23M
Shares Out
$56.71
$99.50
52-Week Range
Institutional Ownership of ANI PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ANI PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2018-Q3 | |||||
| SELL | EXIT | — | — | $57.30 | |
Insider Trading for ANI PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $313K
0
Buys
3
Sells
-313K
Net
0
Grants
Largest
$146K
Tannenbaum
$134K
Davis
$33K
Cook
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | Krista Davis | SVP, CHIEF HR OFFICER | SELL | 1.6K | $82.40 | $134K |
| Dec 12, 2025 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | SELL | 400 | $82.32 | $33K |
| Dec 05, 2025 | Renee P Tannenbaum | Director | SELL | 1.8K | $81.15 | $146K |